基于人群的老年人群视网膜下玻璃膜疣样沉积研究(Montrachet研究)
Montrachet人群研究中,至少一眼可判读的1135名受试者(平均年龄82.3±3.8岁,女性62.7%)视网膜下玻璃膜疣样沉积(SDD)患病率为18.1%(n=205)。多因素分析显示SDD与年龄>85岁、女性、血浆叶黄素/玉米黄质水平正相关,与他汀类药物使用及黄斑中心凹下脉络膜厚度负相关。作者认为SDD在75岁以上人群中患病率高、女性更常见且与较薄脉络膜相关,降脂药物关联需进一步研究。
要点
- 至少一眼可判读的1135名老年人中SDD患病率为18.1%(n=205)。
- 年龄>85岁者SDD风险升高(OR 4.6),女性风险升高(OR 1.7)。
- 他汀类药物使用与SDD负相关(OR 0.5),此关联需进一步研究。
核心结论
- SDD在75岁以上人群中患病率高,女性更常见,并与较薄的脉络膜相关。
- SDD与降脂药物的关联有待进一步研究。
研究设计与样本
- 基于人群的Montrachet研究,受试者接受全面眼科检查,包括彩色眼底照相、黄斑区谱域光学相干断层扫描(SD-OCT)联合红外反射成像。
- 按欧洲眼科流行病学SD-OCT黄斑疾病分类记录SDD及其他年龄相关性黄斑变性病变,并测量黄斑中心凹下脉络膜厚度。
- 分析SDD与临床、人口学因素及血浆维生素E和叶黄素/玉米黄质(L/Z)水平的关联。
主要发现
- 受试者平均年龄82.3±3.8岁,女性占62.7%。
- 至少一眼可判读的受试者(n=1135)中SDD患病率为18.1%(n=205)。
- 多因素分析中,SDD与年龄>85岁正相关(OR 4.6;95%CI 2.8-7.7;P<0.001)。
- SDD与女性正相关(OR 1.7;95%CI 1.2-2.4;P=0.005),与血浆L/Z水平正相关(OR 1.2;95%CI 1.0-1.5;P=0.039)。
- SDD与他汀类药物使用负相关(OR 0.5;95%CI 0.3-0.9;P=0.014),与黄斑中心凹下脉络膜厚度负相关(OR 0.8;95%CI 0.7-0.9;P=0.002)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to investigate the prevalence of subretinal drusenoid deposits (SDD) and to identify associated factors in an elderly population. METHODS: The participants of the population-based Montrachet study underwent an exhaustive ophthalmologic examination, including color fundus photography and macular spectral domain-optical coherence tomography (SD-OCT), coupled with infrared reflectance imaging. The presence of SDD and other age-related macular degeneration lesions, according to the European Eye Epidemiology SD-OCT classification of macular diseases, and subfoveal choroidal thickness were recorded. Moreover, the association of SDD and both clinical and demographic factors as well as plasma levels of vitamin E and lutein/zeaxanthin (L/Z) were analyzed. RESULTS: The mean age of patients was 82.3 ± 3.8 years and 62.7% were female. The prevalence of SDD was 18.1% (n = 205) in the subjects with at least one eye interpretable (n = 1135). In multivariate analysis, SDD was positively associated with increasing age (OR, 4.6; 95% CI, 2.8-7.7; P < 0.001 for subjects aged >85 years), female sex (OR, 1.7; 95% CI, 1.2-2.4; P = 0.005), and plasma L/Z level (OR, 1.2; 95% CI, 1.0-1.5; P = 0.039), and negatively associated with lipid-lowering drugs use (OR, 0.5; 95% CI, 0.3-0.9; P = 0.014 for statin medications) and subfoveal choroidal thickness (OR, 0.8; 95% CI, 0.7-0.9; P = 0.002). CONCLUSIONS: The prevalence of SDD was high in subjects older than 75 years, more frequent in women, and was associated with a thinner choroid. The association with lipid-lowering drugs deserves further investigation.
引用
- Gabrielle PH, Seydou A, Arnould L, et al. Subretinal Drusenoid Deposits in the Elderly in a Population-Based Study (the Montrachet Study). Invest Ophthalmol Vis Sci. 2019. PMID: 31747683. doi:10.1167/iovs.19-27283
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。